-+ 0.00%
-+ 0.00%
-+ 0.00%

Insights into Pacific Biosciences Q4 Earnings

Benzinga·02/12/2026 21:12:08
Listen to the news

Pacific Biosciences (NASDAQ:PACB) just disclosed its Q4 earnings on Thursday, February 12, 2026 at 04:05 PM.

Here's a brief overview of the earnings report.

Earnings

Pacific Biosciences beat estimated earnings by 25.0%, reporting an EPS of $-0.12 versus an estimate of $-0.16.

Revenue was up $5.42 million from the same period last year.

Performance in Previous Earnings

The company beat on EPS by $0.03 in the last quarter, resulting in a 7.05% drop share price change the following day.

Here's a look at Pacific Biosciences's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.15 -0.17 -0.19 -0.21
EPS Actual -0.12 -0.13 -0.15 -0.20
Revenue Estimate 40.08M 36.47M 36.90M 40.16M
Revenue Actual 38.44M 39.77M 37.15M 39.22M

To track all earnings releases for Pacific Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.